Copyright: ©Author(s) 2026.
World J Psychiatry. Oct 19, 2026; 16(10): 121314
Published online Oct 19, 2026. doi: 10.5498/wjp.121314
Published online Oct 19, 2026. doi: 10.5498/wjp.121314
Table 2 Additional composite indices and observed variables included in sensitivity analyses1
| Composite index | Observed variable | Theoretical direction |
| Lipid pathway (lipid index) | Atherogenic index of plasma, AIP = log10(TG/HDL-C) | Positive: Higher AIP → greater atherogenic burden → theoretically higher hypercoagulability risk |
| Inflammation pathway (inflamm index) | Absolute neutrophil count (NEU) | Positive: Higher NEU → higher inflammatory/stress response → theoretically higher hypercoagulability risk |
| Absolute monocyte count (MONO) | Positive: Higher MONO → higher chronic inflammation/monocyte–macrophage activation → theoretically higher hypercoagulability risk | |
| Lactate dehydrogenase (LDH) | Positive: Higher LDH → more tissue damage/inflammatory burden → theoretically higher hypercoagulability risk | |
| Systemic inflammation response index (SIRI = NEU × MONO / LYM) | Positive: Higher SIRI → higher immune-inflammatory burden → theoretically higher hypercoagulability risk | |
| Nutritional/ immune sensitivity indices | CONUT score (albumin + total cholesterol + lymphocyte count) | Positive: Higher CONUT score → worse malnutrition → theoretically worse outcomes/higher hypercoagulability risk |
| Prognostic nutritional index (PNI = ALB + 5 × LYM) | Negative: Higher PNI (better albumin and lymphocyte status) → better nutritional/immune status → theoretically lower hypercoagulability risk | |
| Composite covariates | Observed variable | Theoretical direction |
| Hepatic burden domain (hepatic index) | Alanine aminotransferase (ALT) | Positive: Higher ALT → greater hepatocellular injury → theoretically higher hypercoagulability risk |
| Aspartate aminotransferase (AST) | Positive: Higher AST → greater tissue injury → theoretically higher hypercoagulability risk | |
| Gamma-glutamyl transferase (GGT) | Positive: Higher GGT → greater metabolic/cholestatic burden → theoretically higher hypercoagulability risk | |
| Alkaline phosphatase (ALP) | Positive: Higher ALP → greater biliary/bone metabolic burden → theoretically higher hypercoagulability risk | |
| Total bilirubin (TBIL) | Positive: Higher TBIL → greater hepatic/cholestatic dysfunction → theoretically higher hypercoagulability risk | |
| Direct bilirubin (DBIL) | Positive: Higher DBIL → greater hepatobiliary dysfunction → theoretically higher hypercoagulability risk | |
| Renal burden domain (renal index) | Blood urea nitrogen (BUN) | Positive: Higher BUN → worse renal function/protein metabolism → theoretically higher hypercoagulability risk |
| Serum creatinine (Cr) | Positive: Higher Cr → worse renal function → theoretically higher hypercoagulability risk |
- Citation: Wei J, Du HY, He Q, Jia SS, Luo FG, Wang YC. Glycemic indicators influence hypercoagulability via multisystem pathways in psychiatric inpatients: Structural equation modeling. World J Psychiatry 2026; 16(10): 121314
- URL: https://www.wjgnet.com/2220-3206/full/v16/i10/121314.htm
- DOI: https://dx.doi.org/10.5498/wjp.121314